BEAM
Price
$28.39
Change
-$0.68 (-2.34%)
Updated
Aug 20 closing price
Capitalization
2.93B
80 days until earnings call
Intraday BUY SELL Signals
SABS
Price
$3.70
Change
-$0.08 (-2.12%)
Updated
Aug 20 closing price
Capitalization
336.19M
88 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs SABS

BEAM vs SABS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BEAM vs. SABS commentary
Aug 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and SABS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 21, 2026
Stock price -- (BEAM: $29.07 vs. SABS: $3.78)
Brand notoriety: BEAM and SABS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 102% vs. SABS: 75%
Market capitalization -- BEAM: $2.93B vs. SABS: $336.19M
BEAM [@Biotechnology] is valued at $2.93B. SABS’s [@Biotechnology] market capitalization is $336.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $136.93B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileSABS’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • SABS’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than SABS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while SABS’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • SABS’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than SABS.

Price Growth

BEAM (@Biotechnology) experienced а +8.84% price change this week, while SABS (@Biotechnology) price change was -0.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.88%. For the same industry, the average monthly price growth was +6.80%, and the average quarterly price growth was +2930.12%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 09, 2026.

SABS is expected to report earnings on Nov 17, 2026.

Industries' Descriptions

@Biotechnology (+1.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.93B) has a higher market cap than SABS($336M). BEAM YTD gains are higher at: 4.870 vs. SABS (1.070). SABS has higher annual earnings (EBITDA): 2.89M vs. BEAM (-349.25M). BEAM has more cash in the bank: 1.21B vs. SABS (107M). SABS has less debt than BEAM: SABS (6.17M) vs BEAM (251M). BEAM has higher revenues than SABS: BEAM (164M) vs SABS (0).
BEAMSABSBEAM / SABS
Capitalization2.93B336M873%
EBITDA-349.25M2.89M-12,081%
Gain YTD4.8701.070455%
P/E RatioN/A15.40-
Revenue164M0-
Total Cash1.21B107M1,133%
Total Debt251M6.17M4,066%
FUNDAMENTALS RATINGS
BEAM: Fundamental Ratings
BEAM
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMSABS
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 15 days ago
76%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
84%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
SABS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CIMDX17.860.41
+2.35%
Clarkston Founders Institutional
VKSRX19.220.21
+1.10%
Virtus KAR Small-Mid Cap Core R6
HILDX28.470.12
+0.42%
Hartford International Value F
GSBUX29.020.09
+0.31%
Goldman Sachs Income Builder R6
ACWEX22.70-0.11
-0.48%
Cavanal Hill World Energy & Power C

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+9.41%
CRSP - BEAM
75%
Closely correlated
+12.91%
PRME - BEAM
65%
Loosely correlated
+16.07%
EDIT - BEAM
65%
Loosely correlated
+12.85%
NTLA - BEAM
60%
Loosely correlated
+14.48%
AXON - BEAM
57%
Loosely correlated
+4.17%
More

SABS and

Correlation & Price change

A.I.dvisor indicates that over the last year, SABS has been loosely correlated with REVB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SABS jumps, then REVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SABS
1D Price
Change %
SABS100%
-0.26%
REVB - SABS
48%
Loosely correlated
N/A
INKT - SABS
47%
Loosely correlated
-6.16%
CYPH - SABS
46%
Loosely correlated
+32.85%
TECX - SABS
35%
Loosely correlated
+1.17%
BEAM - SABS
32%
Poorly correlated
+9.41%
More